-
HALVORSEN OLE ANDREAS
2023/05/20
1450000
-500000
2023-05-20
0001725160
0001725160
950000
-
Voliotis Dimitris
2023/05/19
SVP, Clinical Development
119563
-30601
2023-05-19
0001725160
0001725160
88962
-
Voliotis Dimitris
2023/05/18
SVP, Clinical Development
119563
-30601
2023-05-18
0001725160
0001725160
88962
-
Viking Global Opportunities Illiquid Investments Sub-Master LP
2023/05/17
1450000
-500000
2023-05-17
0001725160
0001725160
950000
-
Viking Global Opportunities Illiquid Investments Sub-Master LP
2023/05/16
1450000
-500000
2023-05-16
0001725160
0001725160
950000
-
Viking Global Opportunities Illiquid Investments Sub-Master LP
2023/05/15
1450000
-500000
2023-05-15
0001725160
0001725160
950000
-
Voliotis Dimitris
2023/05/14
SVP, Clinical Development
119563
-30601
2023-05-14
0001725160
0001725160
88962
-
Voliotis Dimitris
2023/05/13
SVP, Clinical Development
119563
-30601
2023-05-13
0001725160
0001725160
88962
-
Epperly Melissa B,
2023/05/12
Chief Financial Officer
459293
-94611
2023-05-12
0001725160
0001725160
364682
-
Epperly Melissa B,
2023/05/11
Chief Financial Officer
459293
-94611
2023-05-11
0001725160
0001725160
364682